IFS Advisors’s GeoVax Labs GOVX Stock Holding History

IFS Advisors’s Portfolio GOVX Stock Details GOVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12	Closed	-$741	–	201
2024 Q4	$741	Buy	+12	New	+$695	﹤0.01%	167

Other funds holding GOVX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

IFS Advisors's GOVX Position: Q1 2025 in Review

IFS Advisors sold out of GeoVax Labs (GOVX) in Q1 2025, closing a stake of 12 shares — an estimated $741 sold.

IFS Advisors first reported a position in GOVX in Q4 2024 and held it in 1 quarter. The position peaked at $741 in Q4 2024. 16 funds tracked by Wall St. Rank hold GOVX as of Q1 2025.

IFS Advisors reported no remaining GeoVax Labs position as of Q1 2025 after selling out during the quarter.
IFS Advisors sold 12 GeoVax Labs shares in Q1 2025, an estimated $741.
IFS Advisors first reported a position in GeoVax Labs in Q4 2024 and held it in 1 quarter.
IFS Advisors's GeoVax Labs position peaked at $741 in Q4 2024.
16 funds tracked by Wall St. Rank held GeoVax Labs as of Q1 2025.

Based on IFS Advisors's 13F filing for Q1 2025, filed 10 Apr 2025.